Objectives: This study evaluated the feasibility and effectiveness of clinical indicator conditions (ICs)-guided and epidemiological risk factors (RF)-based provider-initiated HIV testing in Italian urban Emergency departments (EDs) within the current opt-in legal framework. Methods: A multicenter cross-sectional study was conducted from September 2022 to September 2023 in the EDs of two urban hospitals in Rome and Milan. Adults with one or more pre-defined ICs and/or RFs were offered HIV testing. Demographic, clinical and historical data were collected, and multivariable logistic regression was used to identify predictors of HIV test reactivity. Results: Among 826 enrolled participants, 12 new HIV diagnoses were made, yielding a reactivity rate of 1.45% (95% CI 0.82-2.54). ICs associated with test reactivity included mononucleosis-like illness, seborrheic dermatitis/exanthema, and pneumonia. Key RFs associated with positivity included being a migrant from a high-HIV-endemic country, MSM status, and injection drug use. Most newly diagnosed individuals had CD4+ T lymphocytes counts <350 cells/µL, and missed opportunities for earlier testing were identified in 66.7% of evaluable cases. Conclusion: Provider-initiated HIV testing in EDs guided by ICs and RFs is feasible and effective within the Italian opt-in framework, enhancing early HIV case detection, supporting broader implementation as part of national testing strategies.

Indicator condcition-based and risk-factor guided HIV estting in the emergency department. An effective strategy to increase new diagnoses in Italy / Lazzaro, A., Tincati, C., Romano, F., Santoro, A., Bortolani, L., Santinelli, L., Ceccarelli, G., Galardo, G., Biamonte, F., Marchetti, G., D'Ettorre, G.. - In: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. - ISSN 1878-3511. - 162:(2025), pp. 1-7. [10.1016/j.ijid.2025.108128]

Indicator condcition-based and risk-factor guided HIV estting in the emergency department. An effective strategy to increase new diagnoses in Italy

Lazzaro, A.;Romano, F.;Bortolani, L.;Santinelli, L.;Ceccarelli, G.;Galardo, G.;Biamonte, F.;d'Ettorre, G.
2025

Abstract

Objectives: This study evaluated the feasibility and effectiveness of clinical indicator conditions (ICs)-guided and epidemiological risk factors (RF)-based provider-initiated HIV testing in Italian urban Emergency departments (EDs) within the current opt-in legal framework. Methods: A multicenter cross-sectional study was conducted from September 2022 to September 2023 in the EDs of two urban hospitals in Rome and Milan. Adults with one or more pre-defined ICs and/or RFs were offered HIV testing. Demographic, clinical and historical data were collected, and multivariable logistic regression was used to identify predictors of HIV test reactivity. Results: Among 826 enrolled participants, 12 new HIV diagnoses were made, yielding a reactivity rate of 1.45% (95% CI 0.82-2.54). ICs associated with test reactivity included mononucleosis-like illness, seborrheic dermatitis/exanthema, and pneumonia. Key RFs associated with positivity included being a migrant from a high-HIV-endemic country, MSM status, and injection drug use. Most newly diagnosed individuals had CD4+ T lymphocytes counts <350 cells/µL, and missed opportunities for earlier testing were identified in 66.7% of evaluable cases. Conclusion: Provider-initiated HIV testing in EDs guided by ICs and RFs is feasible and effective within the Italian opt-in framework, enhancing early HIV case detection, supporting broader implementation as part of national testing strategies.
2025
hiv testing; clinical indicator conditions; emergency departments; epidemiological risk factors
01 Pubblicazione su rivista::01a Articolo in rivista
Indicator condcition-based and risk-factor guided HIV estting in the emergency department. An effective strategy to increase new diagnoses in Italy / Lazzaro, A., Tincati, C., Romano, F., Santoro, A., Bortolani, L., Santinelli, L., Ceccarelli, G., Galardo, G., Biamonte, F., Marchetti, G., D'Ettorre, G.. - In: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. - ISSN 1878-3511. - 162:(2025), pp. 1-7. [10.1016/j.ijid.2025.108128]
File allegati a questo prodotto
File Dimensione Formato  
Lazzaro_Indicator_2026.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 619.26 kB
Formato Adobe PDF
619.26 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1780217
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact